Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
29
pubmed:dateCreated
2004-7-12
pubmed:abstractText
The E1 and E2 glycoproteins of hepatitis C virus form a noncovalently associated heterodimer that mediates viral entry. Glycoprotein E2 comprises a receptor-binding domain (residues 384-661) that is connected to the transmembrane domain (residues 716-746) via a highly conserved sequence containing a hydrophobic heptad repeat (residues 675-699). Alanine- and proline-scanning mutagenesis of the E2 heptad repeat revealed that Leu675, Ser678, Leu689, and Leu692 are important for E1E2 heterodimerization. Furthermore, Pro and Ala substitution of all but one heptad repeat residue (Ser678) blocked the entry of E1E2-HIV-1 pseudotypes into Huh7 cells, irrespective of an effect on heterodimerization. Two conserved prolines (Pro676 and Pro683), occupying consecutive b positions of the heptad, were not required for E1E2 heterodimerization; however, Pro683 was critical for viral entry. Thus, disruption of the predicted alpha-helical structure by proline at position 683 is important for E2 function. The inability of mutants to mediate viral entry was not explained by a loss of receptor binding function, because all mutants were able to interact with a recombinant form of the CD81 large extracellular loop. Chimeras formed between the E1 and E2 ectodomains and the transmembrane domains of flavivirus prM and E glycoproteins, respectively, were able to heterodimerize, although with lower efficiency in comparison with wild type E1E2. The heptad repeat of E2 therefore requires the native transmembrane domain for full heterodimerization and viral entry function. Our data indicate that the membraneproximal heptad repeat of E2 is functionally homologous to the stem of flavivirus E glycoproteins. We propose that E2 has mechanistic features in common with class II fusion proteins.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0021-9258
pubmed:author
pubmed:issnType
Print
pubmed:day
16
pubmed:volume
279
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
30066-72
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:15136562-Alanine, pubmed-meshheading:15136562-Amino Acid Sequence, pubmed-meshheading:15136562-Animals, pubmed-meshheading:15136562-Blotting, Western, pubmed-meshheading:15136562-COS Cells, pubmed-meshheading:15136562-Cell Line, pubmed-meshheading:15136562-Dimerization, pubmed-meshheading:15136562-Genetic Vectors, pubmed-meshheading:15136562-Glycoproteins, pubmed-meshheading:15136562-Humans, pubmed-meshheading:15136562-Molecular Sequence Data, pubmed-meshheading:15136562-Mutagenesis, Site-Directed, pubmed-meshheading:15136562-Mutation, pubmed-meshheading:15136562-Precipitin Tests, pubmed-meshheading:15136562-Proline, pubmed-meshheading:15136562-Protein Binding, pubmed-meshheading:15136562-Protein Structure, Tertiary, pubmed-meshheading:15136562-Recombinant Proteins, pubmed-meshheading:15136562-Serine, pubmed-meshheading:15136562-Transfection, pubmed-meshheading:15136562-Viral Envelope Proteins
pubmed:year
2004
pubmed:articleTitle
Hepatitis C virus glycoprotein E2 contains a membrane-proximal heptad repeat sequence that is essential for E1E2 glycoprotein heterodimerization and viral entry.
pubmed:affiliation
St. Vincent's Institute of Medical Research, 41 Victoria Pde Fitzroy, Victoria Australia 3065. heidid@ariel.its.unimelb.edu.au
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't